CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

ONCOLOGY. Vol. 19 No. 11
COMMENTARY 

Language, the Literature, and the Patient

By Terry Altilio, LMSW
Social Work Coordinator
Department of Pain Medicine
and Palliative Care
Beth Israel Medical Center
New York, New York

Stewart B. Fleishman, MD
Director, Cancer Supportive Services
Continuum Cancer Centers
of New York
Beth Israel Medical Center and
St Luke’s-Roosevelt Hospital Center
New York, New York

Shirley Otis-Green, MSW, ACSW,
OSW-C, LCSW
Senior Research Specialist
Nursing Research and
Education Department
City of Hope
National Medical Center
Duarte, California

| October 1, 2005

The articles and accompanying commentaries in ONCOLOGY provide important clinical information but also an opportunity to call attention to language projecting attitudes and judgments that are unintended, probably unconscious, and generally unchallenged. We note that recent articles and reviews refer to the "patient having failed" treatment; patients are identified with their cancer as if they are one, and the description of therapy as "salvage" indirectly compares the human experience of treating patients to saving, rescuing, or restoring goods. Patients become their cancer when they are described as "progressing" during chemotherapy. When patients are described as "failing," it is a tribute to the way the culture of medicine has adopted this language as if it is an accurate reflection of the treatment realities. As palliative care principles are actively integrated into ongoing oncology care, we discuss "salvage therapy" for many patients who "fail palliative chemotherapy" and are "in sufficiently good condition to receive additional therapy." But regardless of performance status, patients, when viewed as unique individuals in the context of values, beliefs, and lives beyond their cancer may engage in a decision-making process that considers performance status as only one of many significant variables. The language that we perpetuate in professional literature and in our training of new clinicians has the power to portray an accurate, compassionate approach, rather than the unconscious portrayal of patients as damaged goods and, in the setting of progressing disease, "failures." The Editors Reply Thank you for your correspondence. We recognize the danger of shortchanging and dehumanizing the patient by acceptance of such verbiage as "patients having failed" and "salvage" therapy. We know too that such jargon is pervasive in the oncology literature. And we have found that to eliminate it completely is a challenging and difficult goal. In editing manuscripts for publication, we will often convert a phrase such as "the patient progressed" to "disease progressed," as a matter of sensitivity as much as for the sake of good and accurate English. With some papers, however, such editing can be an uphill battle. There are not always ready and appropriate alternatives, and in many cases we allow that the possibly less compassionate term or phrase is that which is most clearly understood and accepted in the oncology community. That said, we appreciate your letter, and most importantly, the reminder that patients are people, surely deserving of more respect and sensitivity than they are sometimes accorded in the medical literature.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
IMAGE IQ

Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
James B. Yu, MD1 , May 17, 2013

A 70-year-old man with a history of localized prostate cancer treated with whole-pelvis radiation therapy with a boost to the prostate, in conjunction with androgen deprivation therapy 7 years prior, presented with lower back pain. A bone scan revealed an area of activity in the sacrum. What is the most likely diagnosis?

More Image IQs 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Colorectal Lesions
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
  • Staying Fit Could Ward Off Lung and Colorectal Cancer for Middle-Age Men
  • Obesity Impairs Efficacy of L-Asparaginase in Leukemia Treatment
  • New AUA Guidelines for Prostate Cancer Screening
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Preventing Exposure to Hazardous Drugs
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
Click here to subscribe to our newsletter



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy